Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMonchhichi PLC Regulatory News (MCC)

  • There is currently no data for MCC

PDMR transactions and board changes

23 Dec 2016 09:02

RNS Number : 6999S
Mercom Capital Plc
23 December 2016
 

23 December 2016

Mercom Capital Plc

("Mercom" or the "Company")

Completion of PDMR transactions

Board and senior management changes

Issue of equity and total voting rights

 

Completion of PDMR transactions

Further to the announcement made on 21 December 2016, the Company has been notified of the following transactions by the Directors in relation to their shares and warrants (the "Directors' Share Transaction"):

 

Number of shares/warrants

Transaction

Patrick Cross

906,957 shares

All shares sold

John Zorbas

4,998,595 shares

All shares sold

1,200,000 warrants

All warrants exercised at 5p per share and all shares arising sold

Kyle Appleby

 

1,590,081 shares

Call option granted over all shares held*

300,000 warrants

All warrants exercised at 5p per share and all shares arising sold

* Under the terms of the call option, Mr Appleby has granted Calvet International Limited an option to acquire 1,590,081 shares in the Company at a price of 18p per share at any time prior to 31 January 2017. Calvet has the right to assign the option.

All shares sold by Patrick Cross, Kyle Appleby and John Zorbas were sold at 20p per share, of which 2p per share is to be returned to the Company.

Board and company secretary appointments

Immediately following the Directors' Share Transaction, Mr Simon Fry, Mr Felipe Simonsen and Mr Jean-Pascal Tranié were appointed as directors of the Company, with Mr Fry being appointed as Executive Chairman, Mr Simonsen as Finance Director and Mr Tranié as Senior Non-Executive Director (the "New Board"). Information on the New Board as required by paragraph (g) of Schedule Two to the AIM Rules is set out at the end of this announcement.

In addition, Stuart Davies has been appointed as Company Secretary.

Immediately following the board appointments, Patrick Cross, John Zorbas and Kyle Appleby stood down as Directors of Mercom.

Exercise of Warrants

The Company has issued and allotted a total of 1,500,000 shares pursuant to the exercise of warrants held by John Zorbas and Kyle Appleby. These shares were admitted to trading on AIM as part of the block admission announced on 20 July 2016. In addition, the Company has issued and allotted 250,000 shares following exercise of warrants granted to Northland Capital Partners Limited in July 2016. The warrants were exercised at a price of 5p per share. Application has been made for these 250,000 shares, which rank pari passu with the Company's existing shares, to be admitted to trading on AIM ("Admission"). It is anticipated that Admission will be effective on 28 December 2016.

Following the above allotments and issues of, in aggregate, 1,750,000 shares, the Company's issued share capital consists of 36,576,773 shares with voting rights and, at this point in time, no warrants remain outstanding. There are no shares held in treasury. Therefore the total number of voting rights is 36,576,773. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

As part of the secondary placing, Simon Fry has acquired 500,000 shares (1.37 per cent.) through his SIPP and Jean-Pascal Tranié has acquired 625,000 shares (1.71 per cent.).

 

In addition the Company is pleased to inform shareholders of the following:

 

· the immediate appointments of Cooley (UK) LLP as external legal counsel and Buchanan Communications as financial communications consultants;

 

· the intention of the new Directors to convene a General Meeting as soon as practical to approve inter alia the proposed change in Investing Policy and Company name as well as increased authorities in respect of the allotment of shares and the disapplication of pre-emption rights; and

 

· the AGM convened for 5 January 2017 will proceed as planned.

 

Commenting on today's announcement, Simon Fry said:

 

"We would like to thank the Advisors to the Company for their collective efforts during the past two months that ensured that as of today a new and defining chapter can start for the Company. In due course, I shall be writing to shareholders to explain in more details the investment plans we have been formulating for the Company. My newly appointed fellow Board members and I are confident that over time this shall lead to a complete transformation of the Company."

 

Enquiries:

 

Mercom Capital Plc

Simon Fry

 

+44 (0)20 7466 5000

Northland Capital Partners Limited

Nominated Adviser and Broker

Edward Hutton / Matthew Johnson

 

+44 (0)20 3861 6625

Buchanan Communications

Financial communications consultants

Richard Oldworth

 

+44 (0)20 7466 5000

 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

 

Further information on the New Board

Further information on the New Board pursuant to Schedule Two, paragraph (g) of the AIM Rules is set out below:

Simon Jeremy Fry (age 57)

Current directorships or partnerships

Directorships or partnerships in the last five years

5161 LLC

Imvio LLC

Envision Consulting SA

KX Gym Limited

Fansz North America Limited

Fansz Limited

Pursuant to paragraph (g) (v) of Schedule Two to the AIM Rules, Simon Fry has disclosed that:

· Fansz North America Limited, a social media start-up subsidiary registered in Delaware, was put into voluntary liquidation in December 2015. KPMG was appointed as liquidator. There were no creditors. The credit balance was circa + US$2,500; and

· Fansz Limited, a social media start-up holding company, registered in Guernsey, was put into voluntary liquidation in December 2015. KPMG was appointed as liquidator. At last count there were creditors circa US$1,300,000 (generally office leases and professional services/employees) against assets of circa US$500,000. KPMG are continuing to finalise the liquidation.

Jean-Pascal Michel Marie Tranié (age 57)

Current directorships or partnerships

Directorships or partnerships in the last five years

Aloe Private Equity S.A.S.

Aloe Private Equity (UK) Limited

Green Cross France et Territoires

Aloem

 SCI De Tonneville

Provensol I

Lavansol III

Lavansol IV

Chateau Solar I

Chateau Solar IV

Chateau Solar II

Durancialis I

Durancialis II

Ferrasol

Camargue I

Soleol IV

SCI 2 Rouvray

CS Communication & Systèmes

PerPetual Ltd

Green Investment Group Ltd

Green Investment Group Advisory

Agrogeneration S.A.

Assystem S.A.

Edenworld EURL

Felipe Wallace Simonsen (age 45) 

Current directorships or partnerships

Directorships or partnerships in the last five years

Altere Securitizadora S.A.

S.G. Consultoria Financeira S/S Limitada

Fansz Latam Tecnologia Limitada

Ci Serv Servicos e Administracao Limitada

Fs Consultoria Eireli- ME

 

 

There is no other information in respect of the New Board that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules.

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFEWSMDFMSEEE
Date   Source Headline
25th Jan 20183:54 pmRNSInterim Results & Sentiance Update
20th Dec 201712:15 pmRNSUpdate on Move to Standard List of the Main Market
10th Nov 20177:00 amRNSMarket Update & Appointment of Directors
24th Oct 201711:33 amRNSResult of Annual General Meeting
13th Oct 20175:59 pmRNSUpdate
22nd Sep 20177:00 amRNSInvestment in Sentiance
20th Sep 20172:05 pmRNSResults for the year ended 31 March 2017
14th Sep 20177:00 amRNSProgress Update and Proposed admission
28th Jul 201710:30 amRNSMedia speculation and suspension of shares
28th Jul 201710:30 amRNSSuspension - Monchhichi Plc
27th Jun 201711:05 amRNSDISCLOSABLE INTEREST
13th Jun 20172:31 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Jun 201710:40 amRNSInvestment Warrants and Directors' Interests
5th May 20178:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th May 20178:00 amRNSDirector Share Purchase
20th Apr 20172:15 pmRNSExercise of Warrants and Issue of Equity
3rd Apr 20179:05 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Apr 20179:05 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
29th Mar 201711:00 amRNSExercise of Warrants and Issue of Equity
29th Mar 20177:00 amRNSBoard Changes
20th Mar 20173:29 pmRNSExercise of Warrants and Issue of Equity
14th Mar 201712:10 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Mar 20174:40 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st Mar 20174:55 pmRNSConfirmation of Capital Reduction
17th Feb 201711:30 amRNSIncrease in shareholding
17th Feb 201711:29 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Feb 201710:45 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
10th Feb 20177:00 amRNSPlacing
24th Jan 20172:00 pmRNSResult of GM and Appointment of Nomad and Broker
9th Jan 20177:00 amRNSNotice of GM
6th Jan 20172:30 pmRNSHolding(s) in Company
6th Jan 20171:08 pmRNSDirector/PDMR Shareholding
5th Jan 201712:15 pmRNSResult of AGM and issue of bonus warrants
3rd Jan 20173:00 pmRNSOption scheme, Calvet option and equity issues
30th Dec 20167:00 amRNSTotal Voting Rights
29th Dec 20166:17 pmRNSHolding(s) in Company
28th Dec 20167:00 amRNSHolding(s) in Company
28th Dec 20167:00 amRNSCorrection: PDMR transactions and board changes
28th Dec 20167:00 amRNSHolding(s) in Company
23rd Dec 20169:02 amRNSPDMR transactions and board changes
21st Dec 20167:00 amRNSCalvet proposal update and proposed board changes
15th Dec 20164:26 pmRNSHolding(s) in Company
13th Dec 20163:40 pmRNSExercise of Warrants
9th Dec 20165:00 pmRNSHolding(s) in Company
8th Dec 20166:20 pmRNSIssue of Equity
2nd Dec 201611:49 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSUpdate on Calvet proposal, AGM, Interim Results
30th Nov 20165:00 pmRNSIssue of equity and total voting rights
21st Nov 20167:00 amRNSChange of Registered Office
27th Oct 20163:05 pmRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.